Active Ingredient(s): Pegfilgrastim-bmez
FDA Approved: * November 4, 2019
Pharm Company: * SANDOZ INC
Category: Cancer

Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.[5] It serves to stimulate the production of white blood cells (neutrophils).[5][7] Pegfilgrastim was developed by Amgen.[8] Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemo... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ziextenzo 6 mg/.6ml Subcutaneous Injection
NDC: 61314-866
Sandoz Inc

Related Brands

Drugs with the same active ingredients